AKT1 and acute myeloid leukemia: Sun et al. revealed that prazosin exerted a therapeutic effect on acute myeloid leukemia by downregulating TNS1 expression and inhibiting the phosphorylation of Akt and mTOR in the PI3K/Akt/mTOR pathway, which in turn inhibited cell proliferation and promotes apoptosis [17].